Strumento inattivo

Altre lingue Ibio Inc Nyse

Azioni

US4510331048

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

IBio Closes Sale of Manufacturing Facility in Texas	03/06
Texas A&M University System Board of Regents acquired Manufacturing facility located in Bryan, Texas of iBio, Inc. for $8.5 million.	03/06
IBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	13/05
Ibio, Inc. Appoints Dr. Martin Brenner, to the Board of Directors, Effective June 1, 2024	13/05
IBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update	13/05
IBio, Inc. announced that it has received $15.066157 million in funding from ADAR1 Capital Management, LLC, Lynx1 Capital Management LP, Ikarian Capital, LLC and other investors	01/04
Top Premarket Gainers	28/03
Top Midday Gainers	27/03
Wall Street Set to Open Higher Wednesday as Investors Eye End-of-Week Economic, Inflation Data	27/03
US Futures Trend Higher Wednesday Pre-Bell as Investors Eye Impending Economic, Inflation Data Readings	27/03
Top Premarket Gainers	27/03
IBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases	27/03
IBio, Inc. and AstralBio, Inc. Announce Transformative AI Drug Discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases	27/03
IBio Announces $15.0 Million Private Placement	27/03
IBio, Inc. announced that it has received $14 million in funding	26/03
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	26/02
IBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka	26/02
Otsuka Pharmaceutical Co., Ltd. completed the acquisition of Preclinical PD-1 Agonist Antibody Program of iBio, Inc..	25/02
IBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	09/02
IBio Announces Participation in 23rd Annual PepTalk Conference	16/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ibio Inc Nyse

Azioni

US4510331048

Altre lingue

Filtri